Protective effect of desferrioxamin against TPA caused inflammation in CD-1 mouse skin
- 31 December 1996
- journal article
- research article
- Published by Elsevier in Surgical Oncology
- Vol. 5 (5-6) , 253-258
- https://doi.org/10.1016/s0960-7404(96)80029-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Antitumor effect of deferoxamine on human hepatocellular carcinoma growing in athymic nude miceCancer, 1992
- Multistage carcinogenesis in mouse skinPharmacology & Therapeutics, 1992
- Pathophysiology of ischaemia reperfusion injury: Central role of the neutrophilBritish Journal of Surgery, 1991
- Early treatment with deferoxamine limits myocardial ischemic/reperfusion injuryFree Radical Biology & Medicine, 1989
- The mechanism of skin tumor promotion caused by phorbol esters: Possible involvement of arachidonic acid cascade/lipoxygenase, protein kinase C and calcium/calmodulin systems.The Japanese Journal of Pharmacology, 1989
- [4] Role of iron in oxygen radical reactionsPublished by Elsevier ,1984
- Overview of tumor promotion in animalsEnvironmental Health Perspectives, 1983
- Suppression of natural antitumour defence mechanisms by phorbol estersNature, 1979
- Inhibitors of Chemical CarcinogenesisPublished by Elsevier ,1978
- Effect of Iron Deficiency and Desferrioxamine on DNA Synthesis in Human CellsBritish Journal of Haematology, 1976